Get startedLog in
    Picture of Invex Therapeutics logo

    IXC — Invex Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Australia Stock Exchange release from INVEX THERAPEUTI : Global Phase 3 Trial of Presendin to Launch in Q4 2021

    Picture of Invex Therapeutics logoInvex Therapeutics
    03/11/2021 22:12
    Australia Stock Exchange release from INVEX THERAPEUTI  IXC.AX : Global Phase 3 Trial of Presendin to Launch in Q4 2021

    Recent news on Invex Therapeutics

    See all news